Key result
In rats, AT1 blockade with losartan decreased Ang II-induced vascular growth (-11%), while combined AT1/AT2 blockade abrogated growth but increased vascular stiffness and MMP-2 activity.
Why the study?
Does combined AT1 and AT2 receptor blockade alter vascular remodeling and matrix metalloproteinases in resistance arteries induced by Angiotensin II in Sprague-Dawley rats?
Population
Sprague-Dawley rats
Comparison
Angiotensin II +/- the AT1 antagonist losartan… vs Angiotensin II alone and controls
Design
Preclinical
Follow-up
7 days
Authors
Loading...
Warrants caution extrapolating rat AT1/AT2 effects to patients; extends mechanistic insights but leaves open clinical relevance.
Does combined AT1 and AT2 receptor blockade alter vascular remodeling and matrix metalloproteinases in resistance arteries induced by Angiotensin II in Sprague-Dawley rats?
AT1 and AT2 receptors exert opposing roles in vascular remodeling, where AT1 blockade reduces stiffness and AT2 blockade decreases MMP-2 and increases elastin.
Brassard et al. (2005) studied Vascular remodeling. Losartan, Sar1-Ile8-Ang II, or hydralazine vs. Ang II alone and controls was evaluated on Growth index and vascular stiffness. In rats, AT1 blockade with losartan decreased Ang II-induced vascular growth (-11%), while combined AT1/AT2 blockade abrogated growth but increased vascular stiffness and MMP-2 activity.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: